Positioning biologics-A case-based discussion: Anti-tumor necrosis factor biological agents/biosimilars.

Leong, Rupert W; Katelaris, Peter H

Leong, Rupert W; Katelaris, Peter H.

Affiliation

Leong RW; Concord Hospital, Sydney, Australia.
Katelaris PH; Gastroenterology Department, Concord Hospital, Sydney and the University of Sydney, Sydney, Australia.

J Gastroenterol Hepatol ; 33 Suppl 3: 14, 2018 Sep.

Article in En | MEDLINE | ID: mdl-30187561

Subject(s)

Antibodies, Monoclonal; Biosimilar Pharmaceuticals; Inflammatory Bowel Diseases/drug therapy; Tumor Necrosis Factor-alpha/immunology; Antibodies, Monoclonal/therapeutic use; Australia; Biosimilar Pharmaceuticals/economics; Biosimilar Pharmaceuticals/therapeutic use; Drug Costs; Drug Monitoring; Drug Utilization/statistics & numerical data; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Tumor Necrosis Factor-alpha / Biosimilar Pharmaceuticals / Antibodies, Monoclonal Limits: Humans Country/Region as subject: Oceania Language: En Journal: J Gastroenterol Hepatol Journal subject: GASTROENTEROLOGIA Year: 2018 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google